Not as expected, unlike in cancer cachexia models, Ddit4 showed a mild upregulation in the muscles in denervated and fasting models but not significantly altered in other muscle atrophy models such as immobilization, Huntingdon disease, and rapamycin-treated mice (Fig. 6C). Here, DDIT4 is linked to muscle atrophy.